newsfilter
← Latest News
PR Newswire·

Nuvalent Appoints Ron Squarer to Board of Directors

Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven...